| 1 |
Targeting alpha-synuclein with the lipoxygenase inhibitor PTC-041 as a therapeutic approach for the treatment of Parkinsons disease
Angela Minnella |
9 |
 |
| 2 |
The prolyl oligopeptidase and -synuclein connection context, insights and hypotheses
Anne Marie Lambeir |
2 |
 |
| 3 |
Chr17q2131 locus risk haplotype H1 susceptibility to Ferroptosis is mediated by the endolysosomal system
Eldem Sadikoglou |
15 |
 |
| 4 |
Telomerase in brain and neurodegeneration
Gabriele Saretzki |
6 |
 |
| 5 |
Lactoferrin and Altered Immune Response Novel Insights into the Link Between Periodontitis and Alzheimers disease
Hoda Tayebi Hillali |
7 |
 |
| 6 |
Model of environment dependent amyloid transformation
Irena Roterman |
19 |
 |
| 7 |
Mitophagy in Alzheimers disease and its potential as a therapeutic target
Jiahua Wei |
3 |
 |
| 8 |
A prospective multi-site cohort study on the prevalence of frailty in patients aged over 70 years presenting after serious injury and implications for outcomes
Martie Botha |
1 |
 |
| 9 |
Arousal Threshold and Sleep Stability Endotypes Under Controlled GABAergic Modulation A Prospective Cohort Study
Nyree Penn |
17 |
 |
| 10 |
Brain-specific microRNA-mediated regulation of metabolic homeostasis in Drosophila melanogaster
Pushpa Verma |
20 |
 |
| 11 |
Microglia promotes Amyloid beta accumulation and tau hyperphosphorylation
Shuge Gui |
11 |
 |
| 12 |
From awareness to action How patient organizations are driving DRPLA research forward
Silvia Prades |
5 |
 |
| 13 |
Percentiles of neuromotor functions from 6 to 80 years
Tanja H. Kakebeeke |
4 |
 |
| 14 |
Human immunomodulatory ligand B7-1 mediates synaptic remodeling via the p75 neurotrophin receptor
Victor Danelon |
14 |
 |
| 15 |
Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology
Volha Skrahina |
13 |
 |
| 16 |
Microglia-Mediated Neuroinflammation Drives Neuropathology in Alzheimers Disease during P gingivalis Infection
Zhou Wu |
10 |
 |